Discovery - University of Dundee - Online Publications

Library & Learning Centre

The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively

Standard

The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively. / Klotz, Daniel M; Nelson, Scott A; Kroboth, Karin; Newton, Ian P; Radulescu, Sorina; Ridgway, Rachel A; Sansom, Owen J; Appleton, Paul L; Nathke, Inke S. (Lead / Corresponding author).

In: Journal of Cell Science, Vol. 125, No. P4, 15.02.2012, p. 887-95.

Research output: Contribution to journalArticle

Harvard

Klotz, DM, Nelson, SA, Kroboth, K, Newton, IP, Radulescu, S, Ridgway, RA, Sansom, OJ, Appleton, PL & Nathke, IS 2012, 'The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively' Journal of Cell Science, vol 125, no. P4, pp. 887-95.

APA

Klotz, D. M., Nelson, S. A., Kroboth, K., Newton, I. P., Radulescu, S., Ridgway, R. A., Sansom, O. J., Appleton, P. L., & Nathke, I. S. (2012). The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively. Journal of Cell Science, 125(P4), 887-95doi: 10.1242/jcs.091843

Vancouver

Klotz DM, Nelson SA, Kroboth K, Newton IP, Radulescu S, Ridgway RA et al. The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively. Journal of Cell Science. 2012 Feb 15;125(P4):887-95.

Author

Klotz, Daniel M; Nelson, Scott A; Kroboth, Karin; Newton, Ian P; Radulescu, Sorina; Ridgway, Rachel A; Sansom, Owen J; Appleton, Paul L; Nathke, Inke S. (Lead / Corresponding author) / The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.

In: Journal of Cell Science, Vol. 125, No. P4, 15.02.2012, p. 887-95.

Research output: Contribution to journalArticle

Bibtex - Download

@article{c119c84109354e839747c29cdc30ec36,
title = "The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively",
author = "Klotz, {Daniel M} and Nelson, {Scott A} and Karin Kroboth and Newton, {Ian P} and Sorina Radulescu and Ridgway, {Rachel A} and Sansom, {Owen J} and Appleton, {Paul L} and Nathke, {Inke S.}",
year = "2012",
volume = "125",
number = "P4",
pages = "887--95",
journal = "Journal of Cell Science",
issn = "0021-9533",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively

A1 - Klotz,Daniel M

A1 - Nelson,Scott A

A1 - Kroboth,Karin

A1 - Newton,Ian P

A1 - Radulescu,Sorina

A1 - Ridgway,Rachel A

A1 - Sansom,Owen J

A1 - Appleton,Paul L

A1 - Nathke,Inke S.

AU - Klotz,Daniel M

AU - Nelson,Scott A

AU - Kroboth,Karin

AU - Newton,Ian P

AU - Radulescu,Sorina

AU - Ridgway,Rachel A

AU - Sansom,Owen J

AU - Appleton,Paul L

AU - Nathke,Inke S.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Colorectal cancers commonly carry truncation mutations in the adenomatous polyposis coli (APC) gene. The APC protein contributes to the stabilization of microtubules. Consistently, microtubules in cells lacking APC depolymerize more readily in response to microtubule-destabilizing drugs. This raises the possibility that such agents are suitable for treatment of APC-deficient cancers. However, APC-deficient cells have a compromised spindle assembly checkpoint, which renders them less sensitive to killing by microtubule poisons whose toxicity relies on the induction of prolonged mitotic arrest. Here, we describe the novel discovery that the clinically used microtubule-depolymerizing drug vinorelbine (Navelbine) kills APC-deficient cells in culture and in intestinal tissue more effectively than it kills wild-type cells. This is due to the ability of vinorelbine to kill cells in interphase independently of mitotic arrest. Consistent with a role for p53 in cell death in interphase, depletion of p53 renders cells less sensitive to vinorelbine, but only in the presence of wild-type APC. The pro-apoptotic protein BIM (also known as BCL2L11) is recruited to mitochondria in response to vinorelbine, where it can inhibit the anti-apoptotic protein BCL2, suggesting that BIM mediates vinorelbine-induced cell death. This recruitment of BIM is enhanced in cells lacking APC. Consistently, BIM depletion dampens the selective effect of vinorelbine on these cells. Our findings reveal that vinorelbine is a potential therapeutic agent for colorectal cancer, but they also illustrate the importance of the APC tumour suppressor status when predicting therapeutic efficacy.

AB - Colorectal cancers commonly carry truncation mutations in the adenomatous polyposis coli (APC) gene. The APC protein contributes to the stabilization of microtubules. Consistently, microtubules in cells lacking APC depolymerize more readily in response to microtubule-destabilizing drugs. This raises the possibility that such agents are suitable for treatment of APC-deficient cancers. However, APC-deficient cells have a compromised spindle assembly checkpoint, which renders them less sensitive to killing by microtubule poisons whose toxicity relies on the induction of prolonged mitotic arrest. Here, we describe the novel discovery that the clinically used microtubule-depolymerizing drug vinorelbine (Navelbine) kills APC-deficient cells in culture and in intestinal tissue more effectively than it kills wild-type cells. This is due to the ability of vinorelbine to kill cells in interphase independently of mitotic arrest. Consistent with a role for p53 in cell death in interphase, depletion of p53 renders cells less sensitive to vinorelbine, but only in the presence of wild-type APC. The pro-apoptotic protein BIM (also known as BCL2L11) is recruited to mitochondria in response to vinorelbine, where it can inhibit the anti-apoptotic protein BCL2, suggesting that BIM mediates vinorelbine-induced cell death. This recruitment of BIM is enhanced in cells lacking APC. Consistently, BIM depletion dampens the selective effect of vinorelbine on these cells. Our findings reveal that vinorelbine is a potential therapeutic agent for colorectal cancer, but they also illustrate the importance of the APC tumour suppressor status when predicting therapeutic efficacy.

U2 - 10.1242/jcs.091843

DO - 10.1242/jcs.091843

M1 - Article

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - P4

VL - 125

SP - 887

EP - 895

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy